Back to feed
NVIDIA
NVIDIA
7/2/2026
BIO26 Healthcare Special Address

BIO26 Healthcare Special Address

Short summary

NVIDIA released BioNeMo Agent Toolkit, enabling AI agents to execute hands-on scientific work in biology and chemistry using real tools—protein shape prediction, drug binding analysis, genetic sequencing, and lab experiment suggestions. Major adopters include Eli Lilly, Schrödinger, and Databricks; Anthropic and OpenAI are integrating it into their systems. The toolkit solves a core AI limitation: general chatbots lack the ability to autonomously select and use specialized research tools.

  • NVIDIA released BioNeMo Agent Toolkit enabling AI agents to use real scientific tools
  • Adoption from Eli Lilly, Schrödinger, Databricks; integration by Anthropic and OpenAI
  • Toolkit gives agents the ability to autonomously select specialized research tools for given tasks

Generated with AI, which can make mistakes.

Is this a good recommendation for you?

Comments

Failed to load comments. Please try again.

Explore more